Abstract
Infertility treatment using assisted reproductive technologies in the majority of cases involving the use of various ovarian stimulation protocols to obtain the optimal number of oocytes and embryos. The use of analogues of gonadotropin-releasing hormone in ART programs prevents the synthesis of endogenous gonadotropins, which is necessary for controlled ovarian stimulation to prevent premature luteinization and obtaining mature oocytes. Although the role of luteinizing hormone (LH) in the process of maturation of follicles and oocytes is not in doubt, the prescription of LH-containing preparations for ovarian stimulation should be performed after individual analysis of clinical and anamnesis data of the patient data and laboratory tests.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
